Cardiogenic shock in the context of acute coronary syndromes in Latin America (“LATIN Shock”)

Castillo Costa Y.; Delfino F.; Mauro V.; D´Imperio H.; Adamowski M.; Cortez Sandoval M.A.; Pow Chon Long F.; Macín S.M.; Burgos Acosta J.; Chacón-Díaz M.; Soldán Patiño C.P. · Current Problems in Cardiology (2024) · DOI: 10.1016/j.cpcardiol.2024.102745

Resumen

Cardiogenic shock (CS) is a serious complication of heart attack and constitutes one of its main causes of death. To date, there is no data on its treatment and evolution in Latin America. Objectives: To know the clinical characteristics, treatment strategies, evolution and in-hospital mortality of CS in Latin America. Materials and methods: This is a prospective, multicenter registry of patients hospitalized with CS in the context of acute coronary syndromes (ACS) with and without ST segment elevation for 24 months. Results: 41 Latin American centers participated incorporating patients during the period between October 2021 and September 2023. 278 patients were included. Age: 66 (59-75) years, 70.1 % men. 74.8 % of the cases correspond to ACS with ST elevation, 14.4 % to ACS without ST elevation, 5.7 % to right ventricular infarction and 5.1 % to mechanical complications. CS was present from admission in 60 % of cases. Revascularization: 81.3 %, inotropic use: 97.8 %, ARM: 52.5 %, Swan Ganz: 17 %, intra-aortic balloon pump: 22.2 %. Overall in-hospital mortality was 52.7 %, with no differences between ACS with or without ST. Conclusions: Morbidity and mortality is very high despite the high reperfusion used.